HuGE Literature Finder
Records
1
-
30
| A novel cuproptosis-related prognostic gene signature and validation of differential expression in hepatocellular carcinoma. Frontiers in pharmacology 2023 1 13 1081952. Li Yaoting, Zeng Xuezh |
| ADAM10 Gene Polymorphism and Its Relationship to Hepatocellular Carcinoma in Egyptian HCV Patients Receiving Direct-Acting Antiviral Therapies (DAAs). Asian Pacific journal of cancer prevention : APJCP 2023 1 24 (1): 149-155. Ghanem Samar, El Gedawy Gamalat, Yehia Sania, Bedair Hanan, Awad Samah, Abdel-Razek Wael, Elhelbawy Mostafa, El-Sabaawy Dalia, Elfert Ashraf Yous |
| Molecular subtyping and IMScore based on immune-related pathways, oncogenic pathways, and DNA damage repair pathways for guiding immunotherapy in hepatocellular carcinoma patients. Journal of gastrointestinal oncology 2023 1 13 (6): 3135-3153. Yu Zeyan, Vyungura Olivier, Zhao Yinno |
| Tumor Mutational Burden for Predicting Prognosis and Therapy Outcome of Hepatocellular Carcinoma. International journal of molecular sciences 2023 2 24 (4): . Gabbia Daniela, De Martin Sa |
| A functional variant in the RAD51 3' UTR is associated with survival of hepatocellular carcinoma patients. Gene 2022 Oct 146964. Qiu Moqin, Liu Yingchun, Lin Qiuling, Jiang Yanji, Zhou Zihan, Wen Qiuping, Liang Xiumei, Zhou Xianguo, Yu Hongpi |
| Predicting the prognosis of hepatocellular carcinoma based on the interaction between pyroptosis, apoptosis, and necroptosis. Clinical and experimental medicine 2022 Oct . Qian Fang, Kong Wei, Wang Shuaiqun, Wei K |
| Programmed death-ligand 1 (PD-L1) polymorphisms as predictive biomarkers for the development of liver cirrhosis and hepatocellular carcinoma in HCV Egyptian patients. Tumour virus research 2022 Oct 14 200249. Hassan Marwa, Attia Mohammed Saad, Ali-Eldin Zainab, El Attar Gamal, Elzallat Mohamed, Saad Hany Haroun Kaisar, Isaac Ami |
| Identification of Pyroptosis Gene Signature Related Molecular Pattern, Clinical Implication, and Tumor Immunity in Hepatocellular Carcinoma. Combinatorial chemistry & high throughput screening 2022 Aug . Li Yao-Ting, Zeng Xue-Zh |
| Single Nucleotide Polymorphisms of Toll-like Receptor 4 in Hepatocellular Carcinoma-A Single-Center Study. International journal of molecular sciences 2022 Aug 23 (16): . Androutsakos Theodoros, Bakasis Athanasios-Dimitrios, Pouliakis Abraham, Gazouli Maria, Vallilas Christos, Hatzis Gregori |
| A Ferroptosis-Related LncRNA Signature Associated with Prognosis, Tumor Immune Environment, and Genome Instability in Hepatocellular Carcinoma. Computational and mathematical methods in medicine 2022 8 2022 6284540. Lian Jie, Zhang Chaoyu, Lu Hai |
| A novel cuproptosis-related prognostic signature and potential value in HCC immunotherapy. Frontiers in molecular biosciences 2022 10 9 1001788. Wang Xiang-Xu, Wu Li-Hong, Ji Hongchen, Liu Qing-Qing, Deng Shi-Zhou, Dou Qiong-Yi, Ai Liping, Pan Wei, Zhang Hong-M |
| A pyroptosis-related gene signature predicts prognosis and immune microenvironment in hepatocellular carcinoma. World journal of surgical oncology 2022 6 20 (1): 179. Jin Yifeng, Pu Xiaofan, Ping Dongnan, Huang Chaojie, Ding Guoping, Cao Lipi |
| Cuproptosis regulator-mediated patterns associated with immune in?ltration features and construction of cuproptosis-related signatures to guide immunotherapy. Frontiers in immunology 2022 10 13 945516. Wang Gongjun, Xiao Ruoxi, Zhao Shufen, Sun Libin, Guo Jing, Li Wenqian, Zhang Yuqi, Bian Xiaoqian, Qiu Wensheng, Wang Shas |
| Cuproptosis-Related Risk Score Predicts Prognosis and Characterizes the Tumor Microenvironment in Hepatocellular Carcinoma. Frontiers in immunology 2022 7 13 925618. Zhang Zhen, Zeng Xiangyang, Wu Yinghua, Liu Yang, Zhang Xi, Song Zew |
| Development of a novel immune-related lncRNA prognostic signature for patients with hepatocellular carcinoma. BMC gastroenterology 2022 11 22 (1): 450. Li Rui, Jin Chen, Zhao Weiheng, Liang Rui, Xiong Huih |
| Multi-omics data integration for hepatocellular carcinoma subtyping with multi-kernel learning. Frontiers in genetics 2022 9 13 962870. Wang Jiaying, Miao Yuting, Li Lingmei, Wu Yongqing, Ren Yan, Cui Yuehua, Cao Hongy |
| Non-Apoptotic Programmed Cell Death-Related Gene Signature Correlates With Stemness and Immune Status and Predicts the Responsiveness of Transarterial Chemoembolization in Hepatocellular Carcinoma. Frontiers in cell and developmental biology 2022 5 10 844013. Zhang Guixiong, Fan Wenzhe, Wang Hongyu, Wen Jie, Tan Jizhou, Xue Miao, Li Jiapi |
| Polymorphism AGT2 (rs4762) is involved in the development of dermatologic events: Proof-of-concept in hepatocellular carcinoma patients treated with sorafenib. World journal of hepatology 2022 9 14 (7): 1438-1458. Sapena Víctor, Iavarone Massimo, Boix Loreto, Facchetti Floriana, Guarino Maria, Sanduzzi Zamparelli Marco, Granito Alessandro, Samper Esther, Scartozzi Mario, Corominas Josep, Marisi Giorgia, Díaz Alba, Casadei-Gardini Andrea, Gramantieri Laura, Lampertico Pietro, Morisco Filomena, Torres Ferran, Bruix Jordi, Reig Mar |
| Risk of Hepatocellular Carcinoma in Patients with Various HFE Genotypes. Digestive diseases and sciences 2022 7 68 (1): 312-322. Natarajan Yamini, Patel Parth, Chu Jinna, Yu Xian, Hernaez Ruben, El-Serag Hashem, Kanwal Fasi |
| Somatic mutation and expression of BAP1 in hepatocellular carcinoma: an indicator for ferroptosis and immune checkpoint inhibitor therapies. Journal of Cancer 2022 1 13 (1): 88-101. Yan Yu-Chuan, Meng Guang-Xiao, Ding Zi-Niu, Liu Yan-Feng, Chen Zhi-Qiang, Yan Lun-Jie, Yang Ya-Fei, Liu Hui, Yang Chun-Cheng, Dong Zhao-Ru, Hong Jian-Guo, Li T |
| Synergistic Associations of PNPLA3 I148M Variant, Alcohol Intake, and Obesity With Risk of Cirrhosis, Hepatocellular Carcinoma, and Mortality. JAMA network open 2022 10 5 (10): e2234221. Kim Hyun-Seok, Xiao Xiangjun, Byun Jinyoung, Jun Goo, DeSantis Stacia M, Chen Han, Thrift Aaron P, El-Serag Hashem B, Kanwal Fasiha, Amos Christopher |
| Systematic analysis of the expression profile and prognostic significance of m6A regulators and PD-L1 in hepatocellular carcinoma. Discover. Oncology 2022 11 13 (1): 131. Kong Fanhua, Wang Kunpeng, Wang Liez |
| The Potential Predictive Biomarkers for Advanced Hepatocellular Carcinoma Treated With Anti-Angiogenic Drugs in Combination With PD-1 Antibody. Frontiers in immunology 2022 7 13 930096. Liu Chenxi, Zhu Sihui, Dong Yanbing, Shao Jie, Liu Baorui, Shen J |
| Ultra Deep Sequencing of Circulating Cell-Free DNA as a Potential Tool for Hepatocellular Carcinoma Management. Cancers 2022 8 14 (16): . Higuera Mónica, Vargas-Accarino Elena, Torrens María, Gregori Josep, Salcedo María Teresa, Martínez-Campreciós Joan, Torres Gloria, Bermúdez-Ramos María, Bilbao Itxarone, Guerrero-Murillo Mercedes, Serres-Créixams Xavier, Merino Xavier, Rodríguez-Frías Francisco, Quer Josep, Mínguez Beatr |
| Whole-exome sequencing identifies a set of genes as markers of hepatocellular carcinoma early recurrence. Hepatology international 2022 12 . Shi Huizhong, Zhang Wenwen, Hu Bingyang, Wang Yafei, Zhang Ze, Sun Ying, Mao Guankun, Li Chonghui, Lu Shich |
| Association of PD-L1 gene polymorphisms and circulating sPD-L1 levels with HBV infection susceptibility and related liver disease progression. Gene 2021 9 806 145935. Xuan Hoan Nghiem, Thi Minh Huyen Pham, Dinh Tung Bui, Phuong Giang Dao, Tat Trung Ngo, Tien Sy Bui, Thi Tuan Nguyen, Thi Ngoc Dung Dang, Reddy Pallerla Srinivas, Velavan Thirumalaisamy P, Hong Bang Mai, Huu Song |
| Circulating level of sPD-1 and PD-1 genetic variants are associated with hepatitis B infection and related liver disease progression. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2021 12 115 229-236. Huyen Pham Thi Minh, Dung Dang Thi Ngoc, Weiß Peter Johann, Hoan Phan Quoc, Giang Dao Phuong, Uyen Ngo Thi, Van Tuan Nguyen, Trung Ngo Tat, Velavan Thirumalaisamy P, Song Le Huu, Hoan Nghiem Xu |
| Higher Enhancement Intrahepatic Nodules on the Hepatobiliary Phase of Gd-EOB-DTPA-Enhanced MRI as a Poor Responsive Marker of Anti-PD-1/PD-L1 Monotherapy for Unresectable Hepatocellular Carcinoma. Liver cancer 2021 12 10 (6): 615-628. Aoki Tomoko, Nishida Naoshi, Ueshima Kazuomi, Morita Masahiro, Chishina Hirokazu, Takita Masahiro, Hagiwara Satoru, Ida Hiroshi, Minami Yasunori, Yamada Akira, Sofue Keitaro, Tsurusaki Masakatsu, Kudo Masatos |
| Integrative Functional Genomics Implicated the Key T-/B-Cell Deficiency Regulator RAG1 in Transarterial Chemoembolization of Hepatocellular Carcinoma. Frontiers in cell and developmental biology 2021 9 720791. Xu Yeyang, Wang Teng, Zeng Jiajia, Wang Bowen, Zhou Liqing, Yang Ming, Zhang Li, Zhang Nas |
| Programmed Cell Death 1 and Hepatocellular Carcinoma: An Epochal Story. Journal of gastrointestinal cancer 2021 12 52 (4): 1217-1222. Demirtas Coskun Ozer, Gunduz Fey |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: